APA (7th ed.) Citation

MWC, V., BS, R., L, S., A, L., C, B., M, B., . . . VHJ, v. d. V. (2024). Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study. Cytometry. Part B, Clinical cytometry, 106(4), 252. https://doi.org/10.1002/cyto.b.22143

Chicago Style (17th ed.) Citation

MWC, Verbeek, et al. "Minimal Residual Disease Assessment in B-cell Precursor Acute Lymphoblastic Leukemia by Semi-automated Identification of Normal Hematopoietic Cells: A EuroFlow Study." Cytometry. Part B, Clinical Cytometry 106, no. 4 (2024): 252. https://doi.org/10.1002/cyto.b.22143.

MLA (9th ed.) Citation

MWC, Verbeek, et al. "Minimal Residual Disease Assessment in B-cell Precursor Acute Lymphoblastic Leukemia by Semi-automated Identification of Normal Hematopoietic Cells: A EuroFlow Study." Cytometry. Part B, Clinical Cytometry, vol. 106, no. 4, 2024, p. 252, https://doi.org/10.1002/cyto.b.22143.